TransCode Therapeutics Inc. (RNAZ) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TransCode Therapeutics In...

    NASDAQ: RNAZ · Real-Time Price · USD
    10.20
    0.28 (2.82%)
    At close: Sep 26, 2025, 3:59 PM
    11.00
    7.84%
    After-hours: Sep 26, 2025, 07:36 PM EDT

    TransCode Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.4 -1.25 -160.8 -1.99K
    PEG Ratio
    		 0.01 0.01 -0.01 -16.54
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 -11.66 14.10 1.74K 678.39
    P/FCF Ratio
    		 -1.76 -1.28 -356.09 -2.51K
    P/OCF Ratio
    		 -1.76 -1.28 -358.37 -2.63K
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 -0.02 0.27 n/a n/a
    Quick Ratio
    		 2.56 1.28 1.57 8.97
    Current Ratio
    		 2.56 1.28 1.70 8.97
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -584.07 -347.39 -1.06 -64.7
    Return on Equity
    		 8.30 -11.3 -10.84 -0.34
    Return on Assets
    		 -2.3 -3.59 -4.63 -0.3
    Return on Invested Capital
    		 -3.41 -9.29 -11.52 -0.31
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist